Published briefings
The latest published company result briefings, with company and sector filters when you need a narrower view.
Showing 529-552 of 704 published briefings.
Investment income surged 75% to £56.6m and lifted distribution coverage, but the capital account drove another large total-return loss.
Published 23 April 2026
Read briefingOperating cash outflow narrowed 29.3% to $1.2m, but at $0.74m half-year revenue, runway is now the central question.
Published 28 April 2026
Read briefingThe shell carries $1.0m of cash and $0.9m of borrowings after a capitalisation, but operations burned $0.1m of cash with no acquisition target
Published 23 April 2026
Read briefingTotal assets fell to NZ$11.0m at the lower edge of the historical range ahead of a planned January rights issue.
Published 23 April 2026
Read briefingInterest income up 150% from a tiny base sets an unprecedented growth rate, but Southern Charter remains pre-revenue after the issuer transition.
Published 23 April 2026
Read briefingOperating cash flow turned positive, but a 974bps gross margin step-down and a NZ$1.7m free cash outflow temper the read.
Published 23 April 2026
Read briefingStrong gross-margin expansion was overshadowed by negative operating cash flow in a seasonally light half, with NPAT optics distorted by the
Published 23 April 2026
Read briefingHeadline earnings fell on a portfolio-basis change; the read now sits with leverage trajectory and timing of development completion.
Published 22 April 2026
Read briefingOperating cash flow fell 82% and debtor days hit an unprecedented 56.4 even as Metroglass reported its first revenue acceleration in years.
Published 22 April 2026
Read briefingOperating leverage from a fast-scaling loan book quintupled PBT in a still-small finance company increasingly funded by term deposits.
Published 22 April 2026
Read briefingRevenue fell 23.3% on post-COVID normalisation, but a NZ$58.7m working-capital build left the lifted dividend uncovered by free cash flow.
Published 22 April 2026
Read briefingReported profit barely moved but cash generation evaporated, even as the balance sheet flipped from negative to positive equity.
Published 22 April 2026
Read briefingWith no operating revenue and equity deficit reset from NZD 547.5m to NZD 0.7m, viability now hinges on the pending reverse takeover.
Published 23 April 2026
Read briefingIntegration and consolidation costs for acquired GP practices absorbed the acquired revenue and roughly halved earnings to $0.3m.
Published 22 April 2026
Read briefingInvestment-property revaluation effects drove an unprecedented statutory loss while rental cash earnings grew, but a halved dividend and rising
Published 22 April 2026
Read briefingOperating revenue lifted to $10.7m with EBITDA margin steady at 15.3% and $7.4m of cash held against no material debt.
Published 22 April 2026
Read briefingThe dominant pharmacy segment lost revenue share and earnings while a 30.3% effective tax rate clipped NPAT growth to 17.5%.
Published 22 April 2026
Read briefingPBT grew 14.9% on 2.0% revenue growth, but a $28.5m inventory build cut operating cash flow from $4.5m to $0.0m and turned free cash flow negative.
Published 22 April 2026
Read briefingOperating cash turned positive to NZ$0.1m, but a NZ$0.4m inventory build leaves AFC holding just NZ$1.6k of cash with borrowings up to NZ$0.1m.
Published 28 April 2026
Read briefingUnderwriting strengthened and full-year dividend rose to 6.5c, yet operating cash inflow fell to $59.8m from $98.6m as the capital buffer thinned.
Published 23 April 2026
Read briefingRevenue rose 20.7% but EBITDA fell 33.6%, cash turned net negative and gearing moved well above the historical range as venue capex doubled.
Published 23 April 2026
Read briefingCash fell to $102.9m and free cash burn deepened, leaving the stated FY25 cashflow-positive target dependent on second-half operating leverage.
Published 23 April 2026
Read briefingRevenue rose to $185.0m but PBT barely advanced from $23.2m, with operating working capital absorbing $5.8m versus a $0.3m historical norm.
Published 23 April 2026
Read briefingThe period-shape mismatch makes the headline declines non-comparable, while FY23 dividend guidance of 6.65 cents per share is reiterated.
Published 22 April 2026
Read briefingGet full NZX result briefings by email as new coverage is published.